Red Book Atlas of Pediatric Infectious Diseases

The fifth edition of this best-selling Red Book® image companion aids in the diagnosis and treatment of more than 165 pediatric infectious diseases.
 
Streamline disease recognition and clinical decision-making with more than 1,350 finely detailed color images, combined with step-by-step guidance.

Featured in the Fifth Edition

• Updated guidance on every pediatric infectious disease
• New guidance on coronaviruses, including SARS-CoV-2 and MERS-CoV
• New Pseudomonas aeruginosa Infections chapter
• Images added for Chlamydia pneumoniae, hepatitis D virus, human herpesvirus 8, and more
• Extensively revised Gonococcal Infections chapter and Hepatitis B chapter
• New Clinical Manifestations added for human herpesvirus 8 in young children
• And much more . . .

 
Concise text descriptions guide the reader through the diagnosis, evaluation, and essential management of each condition.
 

• Clinical Manifestations
• Etiology
• Epidemiology
• Diagnostic Tests
• Incubation Period
• Treatment

The American Academy of Pediatrics is an organization of 67,000 primary care pediatricians, pediatric medical subspecialists and pediatric surgical specialists dedicated to the health, safety and well-being of infants, children, adolescents and young adults. The AAP is the largest pediatric publisher in the world, with a diverse list of resources that includes essential clinical and practice management titles and award-winning books for parents.

Dr Tan is Professor of Pediatrics at the Feinberg School of Medicine, Northwestern University, and a Pediatric Infectious Diseases attending; Medical Director of the International Patient and Destination Services Program (IPS); co-Director of the Pediatric Travel Medicine Clinic; and Director of the International Adoptee Clinic at Ann & Robert H. Lurie Children’s Hospital of Chicago, Chicago, Illinois. She is board certified in pediatrics and pediatric infectious diseases.
 
Dr Tan recently served as a member of the Board of Directors of the Infectious Diseases Society of America (IDSA, 2017-2020). She is also a member of the IDSA Education Committee and the chairperson of the IDSA Committee on Diversity, Inclusion, Access & Equity. She has served as Chairperson of the American Academy of Pediatrics (AAP) Section on Infectious Diseases (SOID, 2014-2018) and as a member of the AAP Committee on Infectious Diseases (COID, Redbook Committee, 2010 - 2018). She currently serves as chairperson of the AAP Global Immunization Advocacy Project Advisory Committee and is a technical advisor for the AAP/CDC Global Immunization Advocacy Project, the AAP Antimicrobial Resistance and Stewardship Workgroup―Education Subcommittee, AAP Expert Pertussis Cocooning Advisory Committee, and liaison to the CDC ACIP Pertussis Working Group and the Illinois Chapter of the AAP OB/GYN Immunizations and Pregnancy Outreach Committee. She is a member of the American Board of Pediatrics (ABP) Global Health Task Force Dissemination and Advocacy Work Group. Dr Tan is a member of the Vaccine and Related Biologic Products Advisory Committee (VRBPAC) of the Food and Drug Administration (FDA) and the Board of Scientific Counselors, Office of Infectious Diseases, Centers for Disease Control and Prevention (CDC), where she serves as co-Chair of the AFM Task Force and the Vaccine Confidence Task Force. She served as a member of the Advisory Commission on Childhood Vaccines of the US Department of Health and Human Services from 2016 to 2019.
 
She is the Editor-in-Chief of Contemporary Pediatrics and the American Academy of Pediatrics Red Book Atlas of Pediatric Infectious Diseases and the Red Book: A Quick Diagnostic Deck. She serves on the editorial boards of the Journal of the Pediatric Infectious Diseases Society (Official Journal of the Pediatric Infectious Diseases Society), Internal Medicine Reviews, and Vaccines.
 
She is the Co-Chairperson and US Representative to the International Steering Committee of the Global Pertussis Initiative (GPI); a member and consultant to the Steering Committee of the Latin America Without Pertussis Initiative (PAHEF, SLIPE); a member of the Expert Pertussis Core Team for Latin America & the Caribbean: Pertussis Action Plan 2020; a member of the Board of Directors of the World Association of Infectious Diseases and Immunological Disorders (WAidid); and a member of the US National Pertussis Task Force (AAP and Every Child by Two). She also is a member of the vaccine advisory boards of Merck, Sanofi Pasteur, GSK and Pfizer/Wyeth.